Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
01:39pm, Tuesday, 09'th Feb 2021
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exact Sciences schedules fourth quarter 2020 earnings call
06:00am, Monday, 01'st Feb 2021
MADISON, Wis., Feb. 1, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close of the U.S.
Stock Indexes Hold Tough, But Leaders Struggle: Datadog, Exact Sciences, Freeport McMoRan In Focus
04:18pm, Tuesday, 26'th Jan 2021
Stock indexes hold tough, but leaders struggle: Datadog, Exact Sciences, Freeport McMoRan in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stoc
Exact Sciences: Patching The Acquisitions Together
08:57am, Thursday, 21'st Jan 2021
Exact Sciences: Patching The Acquisitions Together
MADISON, Wis., Jan. 12, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for Cancer Research
Exact Sciences (EXAS) Soars: Stock Adds 9.8% in Session
09:47am, Tuesday, 12'th Jan 2021
Exact Sciences (EXAS) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Why Eli Lilly, Exact Sciences, Biogen Are Trading Higher Today
12:36pm, Monday, 11'th Jan 2021
Exact Sciences (NASDAQ: EXAS) shares are trading higher after the company issued fourth-quarter sales guidance above analyst estimates. Exact Sciences is a molecular diagnostics company focused on the
Why Exact Sciences Stock Is Soaring Today
11:01am, Monday, 11'th Jan 2021
Investors really liked the company's sneak peek at its fourth-quarter results.
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
07:30pm, Sunday, 10'th Jan 2021
MADISON, Wis., Jan. 10, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for the fourth qua
Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
08:25am, Tuesday, 05'th Jan 2021
MADISON, Wis., Jan. 5, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has completed its previously announced acquisition of Thrive Earlier Detection Corp. ("Thrive").
Exact Sciences to participate in J.P. Morgan Healthcare Conference
06:00am, Monday, 28'th Dec 2020
MADISON, Wis., Dec. 28, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participa
3 Stocks Growing Earnings Fast
10:04am, Tuesday, 22'nd Dec 2020
The S&P 500 saw its trailing 12-month real earnings per share (EPS) grow by approximately 1% on average every year over the past five years. The index's share price ($3,694.92 as of Monday) increased
Indexes Close Off Lows After Virus Scare; Nike, Generac, Exact Sciences In Focus
04:04pm, Monday, 21'st Dec 2020
The stock market turned in resilient performance Monday, overcoming early fears of a new coronavirus strain in the U.K. Investor's Business Daily has been helping people invest smarter results by prov
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
09:00am, Friday, 11'th Dec 2020
MADISON, Wis., Dec. 11, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the presentation of new data at the virtual 2020 San Antonio Breast Cancer Symposium (SABCS) building o
Exact Sciences to participate in December investor conference
06:00am, Monday, 23'rd Nov 2020
MADISON, Wis., Nov. 23, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participa
